Singapore markets closed

Samsung Biologics Co.,Ltd. (207940.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
775,000.00-6,000.00 (-0.77%)
At close: 03:30PM KST
Currency in KRW
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts782424
Avg. Estimate2,823.263,363.6913,460.216,084.8
Low estimate2,2732,972.2610,19611,665
High estimate4,5194,21015,63018,714
Year ago EPS1,9922,59713,29013,460.2
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts6162424
Avg. Estimate946.9M955.74M4.13B4.78B
Low estimate687.2M676.1M3.25B3.91B
High estimate979.7M1.09B4.44B5.24B
Year ago sales590.99M637.17M2.94B4.13B
Sales growth (year/est)60.20%50.00%40.40%15.90%
Earnings history31/03/202330/06/202330/09/202331/12/2023
Est. EPS2,128.632,485.973,220.43,296.4
Actual EPS1,9922,5973,3774,084.12
Difference-136.63111.03156.6787.72
Surprise %-6.40%4.50%4.90%23.90%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate2,823.263,363.6913,460.216,084.8
7 days ago2,823.263,376.3813,944.517,454.9
30 days ago3,110.123,394.4913,390.116,153.7
60 days ago3,090.183,362.0614,139.418,055.8
90 days ago3,117.473,367.6313,411.416,146
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/A122
Up last 30 days11108
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1211
Growth estimates207940.KSIndustrySector(s)S&P 500
Current qtr.41.70%N/AN/AN/A
Next qtr.29.50%N/AN/AN/A
Current year1.30%N/AN/AN/A
Next year19.50%N/AN/AN/A
Next 5 years (per annum)24.28%N/AN/AN/A
Past 5 years (per annum)22.88%N/AN/AN/A